18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.
Journal Article (Journal Article)
BACKGROUND: Amyloid deposition is a potential contributor to postoperative cognitive dysfunction. The authors hypothesized that 6-week global cortical amyloid burden, determined by F-florbetapir positron emission tomography, would be greater in those patients manifesting cognitive dysfunction at 6 weeks postoperatively. METHODS: Amyloid deposition was evaluated in cardiac surgical patients at 6 weeks (n = 40) and 1 yr (n = 12); neurocognitive function was assessed at baseline (n = 40), 6 weeks (n = 37), 1 yr (n = 13), and 3 yr (n = 9). The association of 6-week amyloid deposition with cognitive dysfunction was assessed by multivariable regression, accounting for age, years of education, and baseline cognition. Differences between the surgical cohort with cognitive deficit and the Alzheimer's Disease Neuroimaging Initiative cohorts (normal and early/late mild cognitive impairment) was assessed, adjusting for age, education, and apolipoprotein E4 genotype. RESULTS: The authors found that 6-week abnormal global cortical amyloid deposition was not associated with cognitive dysfunction (13 of 37, 35%) at 6 weeks postoperatively (median standard uptake value ratio [interquartile range]: cognitive dysfunction 0.92 [0.89 to 1.07] vs. 0.98 [0.93 to 1.05]; P = 0.455). In post hoc analyses, global cortical amyloid was also not associated with cognitive dysfunction at 1 or 3 yr postoperatively. Amyloid deposition at 6 weeks in the surgical cohort was not different from that in normal Alzheimer's Disease Neuroimaging Initiative subjects, but increased over 1 yr in many areas at a rate greater than in controls. CONCLUSIONS: In this study, postoperative cognitive dysfunction was not associated with 6-week cortical amyloid deposition. The relationship between cognitive dysfunction and regional amyloid burden and the rate of postoperative amyloid deposition merit further investigation.
Full Text
Duke Authors
- Berger, Miles
- Borges-Neto, Salvador
- Browndyke, Jeffrey Nicholas
- D'Amico, Thomas Anthony
- Doraiswamy, P. Murali
- Glower Jr., Donald D.
- Hughes IV, George Charles
- Laskowitz, Daniel Todd
- Li, Yi-Ju
- Lin, Shu Shiuh-Shi
- Mathew, Joseph P.
- Milano, Carmelo Alessio
- Smith, Peter Kent
- Terrando, Niccolò
- Tong, Betty Caroline
Cited Authors
- Klinger, RY; James, OG; Borges-Neto, S; Bisanar, T; Li, Y-J; Qi, W; Berger, M; Terrando, N; Newman, MF; Doraiswamy, PM; Mathew, JP; Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study Group, ; Neurologic Outcomes Research Group (NORG),
Published Date
- April 2018
Published In
Volume / Issue
- 128 / 4
Start / End Page
- 728 - 744
PubMed ID
- 29389750
Pubmed Central ID
- PMC5849499
Electronic International Standard Serial Number (EISSN)
- 1528-1175
Digital Object Identifier (DOI)
- 10.1097/ALN.0000000000002103
Language
- eng
Conference Location
- United States